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Besides its well established role in control of cellular choles-
terol homeostasis, the liver X receptor (LXR) has been impli-
cated in the regulation of hepatic gluconeogenesis. We investi-
gated the role of the major hepatic LXR isoform in hepatic
glucose metabolism during the feeding-to-fasting transition in
vivo. In addition, we explored hepatic glucose sensing by LXR
during carbohydrate refeeding. Lxr/ mice and their wild-
type littermates were subjected to a fasting-refeeding protocol
and hepatic carbohydrate fluxes as well as whole body insulin
sensitivitywere determined in vivoby stable isotopeprocedures.
Lxr/mice showed an impaired response to fasting in terms
of hepatic glycogen depletion and triglyceride accumulation.
Hepatic glucose 6-phosphate turnoverwas reduced in 9-h fasted
Lxr/mice as comparedwith controls. Although hepatic glu-
coneogenic gene expressionwas increased in 9-h fastedLxr/
mice compared with wild-type controls, the actual gluconeo-
genic flux was not affected by Lxr deficiency. Hepatic and
peripheral insulin sensitivity were similar in Lxr/ and wild-
type mice. Compared with wild-type controls, the induction of
hepatic lipogenic gene expression was blunted in carbohydrate-
refed Lxr/ mice, which was associated with lower plasma
triglyceride concentrations. Yet, expression of “classic” LXR
target genes Abca1, Abcg5, and Abcg8 was not affected by Lxr
deficiency in carbohydrate-refed mice. In summary, these stud-
ies identify LXR as a physiologically relevant mediator of the
hepatic response to fasting. However, the data do not support a
role for LXR in hepatic glucose sensing.
Liver X receptors  and  (LXR/,2 NR1H3/NR1H2) are
important players in the transcriptional control of variousmet-
abolic pathways. LXR is predominantly expressed in liver,
intestine, and adipose tissue but is also present in kidney, lung,
and spleen. LXR is expressed in almost all tissues and organs
(1, 2). LXRs can be activated by oxidized cholesterol metabo-
lites (oxysterols), which have been identified to be their natural
ligands. Hence, LXRs act as intracellular “cholesterol sensors”
(3). LXRs induce lipogenic gene expression upon activation,
both directly (4) and indirectly via the transcription factors ste-
rol regulatory element binding protein-1c (SREBP-1c) and car-
bohydrate response element binding protein (ChREBP) (4–7).
Both SREBP-1c andChREBP are involved in control of the con-
version of glucose into fatty acids. Thus, LXRs coordinate the
interactions between sterol and fatty acid metabolism, for
instance to enable cholesterol ester formation during cellular
cholesterol overload. In the past years, several studies have been
published that point toward a role of LXRs in the control of
glucose homeostasis. These studies showed that pharmacolog-
ical LXR activation improves glycemic control in diabetic
rodent models by increasing peripheral glucose disposal (8, 9)
and/or inhibition of hepatic gluconeogenesis (9–12). Mitro et
al. (13) recently reported that physiologically relevant concen-
trations of either glucose or glucose 6-phosphate (G6P) are able
to bind and activate LXR in HepG2 cells. The physiological
relevance of this potential “glucose sensing” role of LXR has
been debated (14–16) and needs to be established.
To explore the physiological relevance of LXR in hepatic glu-
cose metabolism we subjected mice deficient for Lxr, the
major hepatic isoform, to a fasting-refeeding protocol. Lxr/
mice showed an impaired hepatic fasting response in terms of
glycogen depletion and triglyceride (TG) accumulation.
Although gluconeogenic gene expression was increased in 9-h
fasted Lxr/mice compared with wild-type mice, stable iso-
tope infusion revealed the actual gluconeogenic flux was not
affected by Lxr deficiency. G6P turnover was reduced in
Lxr/mice comparedwith wild-typemice. In carbohydrate-
refedLxr/mice, the hepatic lipogenic responsewas blunted
while changes in the expression of the LXR target genesAbca1,
Abcg5, and Abcg8 were similar in wild-type and Lxr/mice.
Taken together, these data imply an important role for LXR in
the control of hepatic glucose metabolism upon fasting, but
they do not support the hypothesis that Lxr acts as a hepatic
glucose sensor.
EXPERIMENTAL PROCEDURES
Animals and Diets—F2 male Lxr/ mice and their wild-
type littermates on a Sv129/OlaHsd C57Bl/6J mixed back-
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ground (17)were housed in a light- and temperature-controlled
facility (lights on 7 a.m. to 7 p.m., 21 °C). Theywere fed standard
laboratory chow ad libitum (RMH-B, Abdiets, Woerden, The
Netherlands) and had free access to water. All experiments
were approved by the Ethics Committee for Animal Experi-
ments of the University of Groningen.
Fasting and Refeeding Experiments—For fasting experiments
we studied separate groups of mice. All mice were killed by
cardiac puncture under isoflurane anesthesia at 8 a.m., either
without being fasted, after a 9-h fast, or after a 24-h fast. For the
refeeding experiments, mice were killed at 8 a.m. after a 24-h
refeeding period with free access to high carbohydrate chow
(38.5% w/w sucrose, Abdiets) following a 24-h fasting period.
Plasma Metabolite Concentrations—Blood glucose concen-
trations weremeasured using a EuroFlash glucosemeter (Lifes-
can Benelux, Beerse, Belgium). Plasma insulin concentrations
were determined using enzyme-linked immunosorbent assay
(UltrasensitiveMouse Insulin kit,Mercodia, Uppsala, Sweden).
Plasma non-esterified fatty acid (NEFA), -hydroxybutyrate
(-HB), TG, and cholesterol concentrations were determined
using commercially available kits (Roche Diagnostics, Mann-
heim, Germany and Wako Chemicals, Neuss, Germany).
Hepatic Metabolite Content and Gene Expression Levels—
Livers were quickly removed, weighed, freeze-clamped, and
stored at80 °C. A small piece of liver was fixed in 4% formalin
in phosphate-buffered saline for histological analysis. Blood
was centrifuged (4000  g for 10 min at 4 °C), and plasma was
stored at 20 °C. Frozen liver was homogenized in ice-cold
saline. Hepatic TG concentrations were analyzed using a com-
mercially available kit (RocheDiagnostics) after lipid extraction
according to Bligh and Dyer (18). Hepatic G6P and glycogen
content were determined as described previously (19, 20). In
addition, hepatic glycogen disposition was visualized by peri-
odic acid-Schiff staining of 3-m-thick liver slices. RNA was
extracted from frozen liver using TRI reagent (Sigma) and sub-
sequently converted into cDNA by a reverse transcription pro-
cedure usingMoloneymurine leukemia virus transcriptase and
random primers according to the manufacturer’s protocol. For
real-time PCR, cDNA was amplified using the appropriate
primers and probes. Primer and probe sequences for 18S, ATP
binding cassette a1/g5/g8 (Abca1/g5/g8), carbohydrate
response element binding protein (Chrebp), fatty acid synthase
(Fas), fructose-1,6-biphosphatase 1 (Fbp1), glucose-6-phos-
phate hydrolase (G6ph), glucose-6-phosphate translocase
(G6pt), peroxisome proliferator activated receptor gamma co-
activator 1 alpha (Pgc-1), phosphoenolpyruvate carboxyki-
nase (Pepck), pyruvate dehydrogenase kinase 4 (Pdk4), stearoyl-
CoA desaturase 1 (Scd1), and sterol regulatory element binding
protein 1c (Srebp-1c) have been published previously (www.
LabPediatricsRug.nl). For acetyl-CoA carboylase 1 (Acc1) the
following primer/probes were used: sense, CCA TCC AAA
CAGAGGGAACATC; antisense, CTACATGAGTCATGC
CAT AGT GGT T; probe, ACG CTA AAC AGA ATG TCC
TTT GCC TCC AAC (accession number NM_133360.2). For
acetyl-CoA carboxylase 2 (Acc2): sense, CCC AGG AGG CTG
CATTGA; antisense, AGACATGCTGGGCCTCATAGTA;
probe, CAC AAG TGA TCC TGAATC TCA CGCGC (acces-
sion numberNM_133904.1). AllmRNA levels were normalized
for 18S expression.
InVivo FluxMeasurements—Micewere equippedwith a per-
manent catheter in the right atrium via the jugular vein (21) and
were allowed a recovery period of at least 3 days. After the
recovery period, the mice were placed in experimental cages
and were fasted from 11 p.m. to 8 a.m. with drinking water
available. All infusion experiments were performed in con-
scious, unrestrained mice. To determine hepatic carbohydrate
fluxes, mice were infused with a solution containing
[U-13C]glucose (7 M), [2-13C]glycerol (82 M), [1-2H]galac-
tose (17 M), and paracetamol (1 mg/ml) during 6 h at an infu-
sion rate of 0.6 ml/h as described previously (22, 23). Blood
glucose concentrationsweremeasured every 30min. Blood and
urine spots were collected every 60min on filter paper. In total,
80–90 l of blood was withdrawn per animal from the tail vein
during these experiments.
Hyperinsulinemic euglycemic clamps were performed in a
separate group ofmice as described earlier (8).Micewere fasted
from 11 p.m. to 8 a.m. the next day with drinking water avail-
able. During 6 h, they were infused with two solutions. The first
solution contained bovine serum albumin (1% w/v, Sigma),
somatostatin (40g/ml, UCB, Breda, TheNetherlands), insulin
(110 milliunits/ml, Actrapid, Novo Nordisk, Bagsvaerd, Den-
mark), glucose (1111mM), and [U-13C]glucose (33mM, 99% 13C
atom percent excess, Cambridge Isotope Laboratories, Ando-
ver, MA) and was infused at a rate of 0.135 ml/h. The second
solution consisted of glucose (1111mM) containing [U-13C]glu-
cose (33 mM). The infusion rate of this solution was variable to
maintain euglycemia. Blood glucose concentrations were
measured every 15 min. Every 30 min, a bloodspot was col-
lected. In total, 150–170l of blood was withdrawn per animal
from the tail vein during these experiments.
TABLE 1
Plasma and liver parameters in Lxr/mice and their wild-type littermates
Mice were fasted for 0, 9, or 24 hours. Blood glucose concentrations were measured using a EuroFlash glucose meter. Plasma insulin, NEFA, -HB, TG, and cholesterol
concentrations were determined using commercially available kits. Values represent means S.E. for n 4–6.
Fed 9-h fasted 24-h fasted
Wild-type Lxr/ Wild-type Lxr/ Wild-type Lxr/
Blood glucose (mM) 8.8 0.3 9.0 0.7 5.2 0.3a 4.8 0.8a 3.5 0.4b 3.6 0.5
Plasma insulin (ng/ml) 1.59 0.38 1.37 0.58 0.12 0.03a 0.13 0.1 0.06 0.01 0.06 0.02
Plasma NEFA (mM) 0.38 0.04 0.48 0.05 0.78 0.05a 0.68 0.04 0.84 0.03 0.78 0.04
Plasma -HB (mM) 0.18 0.04 0.23 0.09 1.57 0.31a 1.12 0.37 3.33 0.25b 3.72 0.19b
Plasma TG (mM) 0.46 0.09 0.47 0.10 0.79 0.09 1.01 0.25 1.25 0.09b 0.91 0.17
Plasma cholesterol (mM) 1.8 0.1 1.6 0.1 2.4 0.1a 1.9 0.1c 1.8 0.2 2.4 0.4
a p 0.05 9-h fasted versus fed.
b p 0.05 24-h fasted versus 9-h fasted.
c p 0.05 Lxr/ versus wild-type (Mann-Whitney U test, p value adjusted for multiple comparisons).
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Analytical procedures for extrac-
tion of glucose from blood spots,
derivatization of the extracted com-
pounds and gas chromatography-
mass spectrometry measurements
of derivatives were performed
according to van Dijk et al. (22–24).
From this, hepatic carbohydrate
fluxes were calculated using mass
isotopomer distribution analysis as
previously described (22, 23, 25).
Supplemental Fig. S1 depicts the
isotopic model used. To balance
input and output of hepatic G6P,
minor adaptations weremade to the
published equations (26). The equa-
tions are given in supplemental
Table S1. Glucose production and
metabolic clearance rates during
hyperinsulinemic euglycemic clamps
were calculated according to Gref-
horst et al. (8).
Statistics—All data are presented
as mean values  S.E. Statistical
analysis was performed using SPSS
for Windows software (SPSS 12.02,
Chicago, IL). Analysis of data
obtained in Lxr/ versus wild-
type mice was assessed by Mann-
Whitney U test for plasma and
liver parameters. In vivo flux data
were analyzed by analysis of
variance for repeated measure-
ments. The null hypothesis was
rejected at the 0.05 level of proba-
bility, except for the fasting-
refeeding experiments, where this
p value was adjusted for multiple
comparisons.
RESULTS
The Fasting Response Is Ham-
pered in Lxr/ Mice—We com-
pared the changes in metabolic
parameters in fasted Lxr/ mice
and wild-type littermate controls.
Upon fasting, blood glucose and
plasma insulin concentrations
decreased while plasma NEFA and
-hydroxybutyrate concentrations
increased, without differences
between Lxr/ and wild-type
mice (Table 1). Plasma TG concen-
trations increased upon fasting in
both genotypes while plasma cho-
lesterol concentrations were not
affected. Compared with wild-type





FIGURE 1. Fasting response in Lxr/mice and their wild-type littermates.Mice were fasted for 0, 9, and
24 h. G6P and glycogen content in liver were determined by an enzymatic assay. Hepatic glycogen was visu-
alized in liver slices of 9-h fasted mice by periodic acid-Schiff staining. Hepatic TG content was analyzed using
a commercial available kit after lipid extraction.A, hepatic G6P content; B, hepatic glycogen content;C, hepatic
glycogen content and localization in 9-h fastedmice. P, periportal; V, perivenous. D, hepatic TG content.Open
bars, wild-typemice; filled bars, Lxr/mice. Values representmeans S.E. for n 4–6; #, p 0.05 9-h fasted
versus fed; §, p 0.05 24-h fasted versus 9-h fasted; *, p 0.05 Lxr/ versuswild-type (Mann-WhitneyU test,
p value adjusted for multiple comparisons).
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to be higher in 9-h fasted Lxr/ mice (Fig. 1A, 73%, p 
0.26). Twenty-four hours of fasting decreased hepatic G6P con-
tent in both phenotypes, but this drop was less pronounced in
Lxr/mice. Hepatic glycogen content decreased upon fast-
ing in both groups (Fig. 1B). However, inwild-typemice hepatic
glycogen content already reached its lowest level after a 9-h fast,
whereas in 9-h fasted Lxr/ mice it was similar to what
observed in the fed state. Histological analysis revealed that the
glycogen in the 9-h fasted Lxr/mice was mainly located in
the periportal zone (Fig. 1C). After 24 h of fasting, hepatic gly-
cogen stores were similarly depleted in both genotypes (Fig.
1B). Hepatic TG content increased upon fasting, but to amark-
edly less extent in Lxr/mice compared with wild-type con-
trols (Fig. 1D).
Gluconeogenic flux plays an essential role in glycogen accu-
mulation (27) and hepatic gluconeogenic gene expression, e.g.
of Pepck andG6pase, has been shown to be decreased upon Lxr
activation (9–11). We therefore determined whether the
increased hepatic glycogen content in the 9-h fasted Lxr/
mice was paralleled by an increased expression of genes encod-
ing enzymes involved in hepatic gluconeogenesis. Compared
with wild-typemice, hepatic expression of Pgc-1, Pepck, Fbp1,
and G6ph (encoding G6P hydrolase, one component of the
multiprotein complex G6Pase) were all increased in 9-h fasted
Lxr/ mice (Fig. 2A). Expression of genes encoding other
major enzymes involved in hepatic carbohydrate metabolism
(G6pt,Gk, Pk, Pdk4, andGp, except forGs, Fig. 2, A and B) was
not affected by Lxr deficiency. Moreover, the lipogenic gene
expression profile was similar in 9-h fasted wild-type and
Lxr/mice, except for a reduction of Acc2 and Scd1 expres-
sion (Fig. 2C).
Impaired Hepatic G6P Metabolism in 9-h Fasted Lxr/
Mice Is Associated with Decreased Glucose Turnover and
Increased Hepatic G6P Content—A 9-h fast uncovered major
differences in hepatic adaptive response betweenwild-type and
Lxr/mice. To determine whether the increased gluconeo-
genic gene expressionwas a cause of the observed differences in
hepatic glycogen andG6P content between 9-h fastedwild-type
and Lxr/ mice, we determined glucose turnover, disposal,
and individual hepatic carbohydrate fluxes using stable isotope
techniques (22, 28). During the infusion of the stable isotopes,
blood glucose concentrations were lower in Lxr/ mice
comparedwithwild-type littermates (Fig. 3A). Steady-state iso-
tope enrichment was reached from 3 h of infusion onwards.
Isotope dilution data during this steady-state situation are
shown inTable 2.Glucose cycling and endogenous glucose pro-
duction were reduced in Lxr/ mice compared with their
wild-type littermates (Fig. 3B), resulting in a decreased total
glucose production. Metabolic glucose clearance was similar in
both groups of mice (Fig. 3C).
Gluconeogenic flux, e.g. de novo synthesis of G6P was not
affected by Lxr deficiency (Table 3). In addition, the compart-
mentation of newly synthesized G6P toward glucose (86 1%
in both Lxr/ and wild-type mice) and glycogen (14 1% in
bothLxr/ andwild-typemice)was comparable in both gen-
otypes. However, glucose phosphorylation (glucokinase flux),
dephosphorylation (glucose-6-phosphatase flux), glycogen
synthesis (glycogen synthase flux), and glycogen breakdown
(glycogen phosphorylase flux) were reduced in Lxr/ mice
compared with wild-type mice (Table 3). G6P turnover and
glucose balance were reduced in Lxr/mice compared with
wild-type littermates, while glycogen balance tended to be less
negative in Lxr/mice (Fig. 4).
Hepatic and Peripheral Insulin Sensitivity AreMaintained in
Lxr/ Mice—Insulin is a major regulator of carbohydrate
metabolism. Although plasma insulin concentrations did not
differ between 9-h fastedwild-type andLxr/mice (Table 1),
we questioned whether insulin sensitivity of hepatic and




FIGURE 2.Hepatic gene expression levels in 9-h fasted Lxr/mice and
their wild-type littermates. A, gluconeogenic gene expression; B, glycolytic
gene expression; and C, lipogenic gene expression. Acc, acetyl CoA carboxyl-
ase; Fas, fatty acid synthase; Fbp1, fructose-1,6-biphosphatase 1; G6ph, glu-
cose-6-phosphatehydrolase;G6pt, glucose-6-phosphate translocase;Gk, glu-
cokinase; Gp, glycogen phosphorylase; Gs, glycogen synthase; Pepck,
phosphoenolpyruvate carboxykinase; Pdk4, pyruvate dehydrogenase kinase
4; Pgc-1, peroxisome proliferator-activated receptor  co-activator 1; Pk,
pyruvate kinase; Scd1, stearoyl-CoA desaturase 1; Srebp-1c, sterol regulatory
element binding protein 1c. Open bars, wild-type mice; filled bars, Lxr/
mice. Values represent means  S.E. for n  5; *, p  0.05 Lxr/ versus
wild-type (Mann-Whitney U test).
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We therefore performed hyperinsulinemic euglycemic clamps
in 9-h fasted conscious, unrestrainedmice. Steady-state isotope
enrichment and euglycemia (Fig. 5A) were reachedwithin 3 h of
infusion. The glucose infusion rates to maintain euglycemic
conditions (Fig. 5B) did not differ between the two genotypes,
indicative for unaffected whole body insulin-sensitivity in
Lxr/ mice compared with wild-type littermates. Hepatic
insulin sensitivity was not affected in Lxr/ mice. Hyperin-
sulinemia resulted in a 41 and 51% reduction of hepatic glucose
production in Lxr/ and wild-type mice, respectively (com-
pare Fig. 5C with Fig. 3B). In addition, peripheral insulin sensi-
tivitywas not affected byLxr deficiency, because theMCRwas
increased to 406% in Lxr/ mice and 378% in wild-type lit-
termates (compare Figs. 5D with 3C).
Carbohydrate Refeeding Affects Hepatic Lipogenesis and
Gene Transcription Independent of LXR—We also deter-
minedwhether there are indications for glucose-mediated LXR
activation. Therefore, plasma and liver metabolite concentra-
tions were assessed in Lxr/ and wild-type mice that were
refed a carbohydrate rich diet following a 24-h fast (Table 4).
Blood glucose and plasma insulin, NEFA, and -hydroxybu-
tyrate concentrations were comparable in both groups of car-
bohydrate-refedmice. PlasmaTGconcentrationswere lower in
carbohydrate-refed Lxr/ mice compared with wild-type
mice, whereas plasma cholesterol concentrations were similar.
Hepatic G6P and glycogen content were increased in carbohy-
drate-refed mice compared to mice that had been fasted for
24 h (Fig. 2,A andB), but no differences were observed between
the two genotypes (Table 4). Hepatic TG content was lower in
carbohydrate-refed Lxr/mice (p 0.052).
In both groups of mice, carbohydrate refeeding increased
expression of Gk, Pk, and Gp, while Pdk4 expression was
decreased. Chrebp and Gs expression were not affected by car-
bohydrate refeeding (Fig. 6A). Expression of Srebp-1c, Acc1,
Fas, and Scd1 was clearly induced in carbohydrate-refed wild-
type mice, but this response was less pronounced in Lxr/
mice.Acc2 expression was not affected by carbohydrate refeed-
ing (Fig. 6B). In bothwild-type andLxr/mice, expression of
the LXR target genesAbca1,Abcg5, andAbcg8was not induced




























































































































FIGURE 3.Wholebodyglucose fluxes in 9-h fasted Lxr/mice and their
wild-type littermates during steady state infusion (t  180–360 min).
Theseparameterswere calculatedusing theequations listed in supplemental
Table S1.A, blood glucose concentrations during isotope infusion.Open dots,
wild-typemice; filled dots, Lxr/mice. B, total glucose production and con-
tribution of endogenous glucose production (dark gray bars) and glucose
cycling (light gray bars). C, metabolic glucose clearance rates.Open bars, wild-
type mice; filled bars, Lxr/mice. Values represent means S.E. for n 6;
*, p  0.05 Lxr/ versus wild-type (analysis of variance for repeated
measurements).
TABLE 2
Primary isotopic parameters during steady state infusion (t 180–
360min) in 9-h fasted Lxr/mice and their wild-type littermates
The parameters were calculated using the equations listed in supplemental Table
S1. Values represent means S.E. for n 6.
Wild-type Lxr/
Isotope dilution
d(glc) 0.016 0.001 0.019 0.001a
d(UDPglc) 0.141 0.008 0.164 0.006a
Isotope exchange
c(glc) 0.27 0.02 0.19 0.01a
c(UDPglc) 0.15 0.03 0.11 0.01
MIDA analysis
f(glc) 0.66 0.03 0.71 0.02
f(UDPglc) 0.54 0.02 0.52 0.01
a p  0.05 Lxr/ versus wild-type (analysis of variance for repeated measure-
ments). For abbreviations see supplemental Table S1.
TABLE 3
Individual fluxes comprising hepatic G6Pmetabolism during steady-
state infusion (t 180–360min) in 9-h fasted Lxr/mice and their
wild-type littermates
The individual fluxes were calculated using the equations listed in supplemental
Table S1. Values represent means in micromoles/kg/min S.E. for n 6.
Wild-type Lxr/
Gluconeogenic flux 109 6 98 4
Glucokinase flux 75 9 39 3a
Glucose-6-phosphatase flux 223 16 158 6a
Glycogen synthase flux 45 4 34 2a
Glycogen phosphorylase flux 71 7 48 4a
a p  0.05 Lxr/ versus wild-type (analysis of variance for repeated
measurements).
LxrMediates the Hepatic Response to Fasting
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LXRs act as cholesterol sensors that control transcription of
genes involved in cellular cholesterol and lipid homeostasis.
Lipid and carbohydrate metabolism are tightly linked and
strongly regulated to ensure an adequate control of whole body
energy metabolism. LXR regulates transcription and activity of
the glucose-sensing lipogenic transcription-factor ChREBP
(4), which strongly suggest a physiological role of LXR in
hepatic carbohydrate metabolism in the postprandial state.
It is known that LXR activation results in hepatic steatosis (5,
29). On the other hand, prolonged fasting is also associated
with hepatic lipid accumulation (30). These lines of evidence
prompted us to study the role of hepatic LXR during fasting
and refeeding. LXR is considered to be the major isoform
regulating lipogenic gene expression in the liver. Therefore,
we subjected Lxr/mice (17) to fasting and refeeding pro-
tocols, and we applied sophisticated stable isotope tech-
niques to quantify hepatic carbohydrate fluxes in vivo in
these mice.
We are the first to show that Lxr plays an important role in
the feeding-to-fasting transition. Lxr deficiency results in an
impaired fasting response, indicated by a delayed fasting-in-
duced hepatic glycogen depletion and increased hepatic G6P
content in 9-h fasted Lxr/ mice compared with wild-type
littermates. Moreover, the Lxr/ mice accumulated less
hepatic TG upon fasting.
Expression of gluconeogenic genes was increased in 9-h
fasted Lxr/mice comparedwithwild-type littermates. This
is in agreement with the decreased expression of Pgc-1,
G6pase, and Pepck upon pharmacological LXR activation
(9–11). However, evaluation of hepatic carbohydrate fluxes in
9-h fasted mice revealed that the induction of gluconeogenic
gene expression in Lxr/ mice was not paralleled by an
increased gluconeogenic flux. Thus, there is a discrepancy
between gene expression levels and gluconeogenic flux in vivo
(8). This indicates that other factors such as precursor availabil-
ity (31, 32) and post-transcriptional modification of enzymes
are important determinants that control hepatic carbohydrate
fluxes in vivo.
Glucose phosphorylation and dephosphorylation as well as
glycogen synthesis and breakdown were reduced in Lxr/
mice compared with wild-type littermates. Thus, instead of an
altered de novo synthesis of G6P the interconversions of G6P,
glucose and glycogen were clearly affected in 9-h fasted
Lxr/ mice. The net effect of the lower glycogen synthesis
(24%) and breakdown (32%) fluxes in Lxr/ mice was a
less negative glycogen balance, supporting the delayed glycogen
depletion observed upon fasting in the Lxr-deficient mice.
FIGURE 4. Hepatic glucose balance, glycogen balance, G6P turnover, and gluconeogenic flux in 9-h fasted Lxr/mice and their wild-type litter-
matesduring steady state infusion (t180–360min).Glucose andglycogenbalanceswere calculated from thedifferencebetween input (glucokinase flux
for glucose balance and glycogen synthase flux for glycogen balance) and output (glucose-6-phosphatase flux for glucose balance and glycogen phospho-
rylase flux for glycogen balance). G6P turnover was calculated from the total G6P input (sum of gluconeogenic flux, glucokinase flux, and glycogen phospho-
rylase flux).Openbars, wild-typemice; filled bars, Lxr/mice. Values representmeansS.E. forn6; *,p0.05 Lxr/ versuswild-type (analysis of variance
for repeated measurements).
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The remaining glycogen was located in the periportal zone. It is
known that upon fasting, glycogen is initially degraded to G6P
in periportal hepatocytes. In perivenous hepatocytes, glycogen
is predominantly broken down into pyruvate and hence
released as lactate (reviewed in Ref. 33). Thus in the livers of 9-h
fasted Lxr/mice, less glycogen was broken down, contrib-
uting to the reduced G6P turnover observed in these mice. The
changes in G6P and glycogen metabolism were not secondary
to changes in hepatic gluconeogenesis (27, 34), because neither
the gluconeogenic flux nor the partitioning of newly synthe-
sized G6P toward glucose and glycogen was affected by Lxr
deficiency. In addition, the net effect of reduced glucokinase
and glucose-6-phosphatase fluxes was a reduction in endoge-
nous glucose production and glucose cycling.
Glycogen synthesis and breakdown are regulated by several
factors, including insulin. Although insulin concentrations
were comparable in 9-h fasted Lxr/ mice and their wild-
type littermates, hepatic insulin sensitivity could have been
altered by Lxr deficiency, explaining the differences observed
in hepatic G6P and glycogen content as well as their intercon-
versions. Hepatic and peripheral insulin sensitivity were deter-
mined in 9-h fasted Lxr/ mice and their wild-type litter-
mates using hyperinsulinemic euglycemic clamps. Insulin
sensitivity of both hepatic glucose production and peripheral
glucose disposal was not affected by Lxr deficiency. Although
LXR agonists have been implicated as potential insulin sensitiz-
ers (9, 10, 12), our data do not support a direct role of LXR as a
potential mediator of hepatic and peripheral insulin sensitivity
(8). However, many of the studies performed on the role of LXR
are based on pharmacological activation. In the Lxr/ mice
there may be some adaptations that prevent the endogenous
ligand from increasing, or there may be additional systems that
compensate for the Lxr deficiency. The reduced hepatic car-
bohydrate fluxes could also be a result from an altered reliance
on glucose versus fatty acids and/or a differential energy
demand in the Lxr/ mice during the feeding-to-fasting
transition. In addition to the delay in glycogen depletion
observed upon fasting in the Lxr/ mice, these mice accu-
mulated remarkably less TG. Gene expression analysis pro-
vided indications for an increase in hepatic fatty acid oxidation
in fasted Lxr/ mice, which could explain this remarkable
reduction in hepatic TG accumulation (data not shown). How-
ever, additional in vivo studies are required to determine the
physiological relevance of these observations.
Finally, we explored the role of LXR in glucose-induced
hepatic lipogenesis. Upon refeeding, hepatic TG content was




















































































































FIGURE 5. Glucose metabolism under hyperinsulinemic euglycemic
clamp conditions in 9-h fasted Lxr/ mice and their wild-type litter-
mates during steady state infusion (t 180–360 min). A, blood glucose
concentrations. B, glucose infusion rates required to maintain euglycemia.
C, endogenous glucose production rates. D, metabolic glucose clearance
rates. Open bars, wild-type mice; filled bars, Lxr/ mice. Values represent
means S.E. for n 5.
TABLE 4
Plasma and liver parameters upon refeeding in Lxr/mice and
their wild-type littermates
Mice were fasted for 24 h and refed a carbohydrate rich diet during 24 h. Blood
glucose concentrations were measured using a EuroFlash glucose meter. Plasma
insulin, NEFA, -HB, TG, and cholesterol concentrations were determined using
commercially available kits. Hepatic G6P and glycogen content were determined
using an enzymatic assay. Hepatic TG content was analyzed using a commercial
available kit after lipid extraction. Values represent means S.E. for n 5–6.
Wild-type Lxr/
Blood glucose (mM) 9.5 0.5 9.8 0.6
Plasma insulin (ng/mL) 1.66 0.49 2.74 0.66
Plasma NEFA (mM) 0.34 0.01 0.30 0.02
Plasma -HB (mM) 0.11 0.01 0.12 0.01
Plasma TG (mM) 3.00 0.18 1.78 0.23a
Plasma cholesterol (mM) 3.7 0.2 3.3 0.1
Hepatic G6P (nmol/g) 347 23 359 41
Hepatic glycogen (mol/g) 1121 81 1088 91
Hepatic TG (mol/g) 18.1 1.5 13.0 1.6
a p 0.05 Lxr/ versus wild-type (Mann-Whitney U-test).
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compared with wild types. Quite strikingly, no differences in
Chrebp expression were observed between Lxr/ and wild-
type mice. This is in contrast to observations by Cha and Repa
(4), which suggested that CHREBP is a downstream target of
LXR. However, carbohydrate refeeding resulted in a less pro-
nounced induction of Srebp-1c and other lipogenic gene
expression in the Lxr/mice compared with the wild-types.
Considering our observation that Chrebp and Pk expression
were similar in carbohydrate-refed Lxr/ and wild-type
mice, we conclude that the blunted lipogenic response in car-
bohydrate-refed Lxr/ mice resulted from the reduced
SREBP-1c activity secondary to Lxr deficiency. Apparently,
the relationship between LXR, ChREBP, and SREBP-1c on the
one hand and hepatic TG metabolism on the other hand
requires further investigation.
Recent in vitro studies have shown that glucose is able to bind
and activate hepatic LXR (13), suggesting that LXRmay act as a
putative hepatic “glucose sensor.” However, the physiological
relevance of glucose sensing by LXR has been debated (14–16)
and therefore required further investigation. In the studies per-
formed by Mitro et al. (13), the expression of the cholesterol
transporters that are direct LXR targets, e.g. Abca1 and Abcg1,
only marginally increased upon carbohydrate-refeeding,
whereas lipogenic mRNA expression was clearly induced.
We confirmed that the expression of the classic LXR-target
genes Abca1, Abcg5, and Abcg8 was not affected by carbohy-
drate-refeeding in Lxr/ mice. Thus, the effect of carbohy-
drate refeeding on hepatic lipogenic gene expression was dif-
ferent from that on expression of the cholesterol transporters
Abca1,Abcg5, andAbcg8. Similar results have been obtained by
Denechaud et al. (16), who showed no induction of hepatic
Abcg1 and Abca1 mRNA expression in carbohydrate-refed
mice, whereas lipogenic gene expression was induced. More-
over, in contrast to the blunted induction of lipogenic gene
expression, Abcg1 and Abca1 expression was not affected in
carbohydrate-refed Lxr/ mice compared with wild-
type controls (16). Taken together, these and our data pro-
vide strong evidence that carbohydrate refeeding does not
induce hepatic gene expression via LXR and, therefore, ques-
tion the physiological relevance of glucose sensing by hepatic
LXR in vivo.
In summary, our data identify LXR as an important player
in control of metabolic adaptation during the feeding-to-fast-
ing transition but question the physiological relevance of glu-
cose sensing by hepatic LXR. In addition to its regulatory role in
cholesterol, lipid, and glucose metabolism to ensure energy
storage in the postprandial state, LXR seems to facilitate the
release of stored energy upon fasting. Under these conditions,
LXR not only mediates TG accumulation, but also controls
hepaticG6P and glycogen deposition, because it determines the
partitioning and turnover of these energy-bearing molecules,
possibly to fulfill the liver’s demand for these metabolites.
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d(glc), fractional contribution of infused glucose to blood glucose; M6(glc)infusate, mole percent enrichments 
(MPE) of [U-13C]glucose in the infusate; M6(glc)blood, MPE of [U-13C]glucose in blood; d(UDPglc), 
fractional contribution of infused galactose to UDPglucose; M1(gal)infusate, MPE of [1-2H]galactose in the 
infusate; M1(pGlcUA)urine, MPE of [1-2H]-UDPglucose measured in urinary Par-GlcUA; c(glc), fractional 
contribution of blood glucose to UDP-glucose formation; M6(pGlcUA)urine, MPE of [U-13C]- UDPglucose 
measured in urinary Par-GlcUA; c(UDPglc), fractional contribution of UDPglucose to blood glucose 
formation; M1(glc)blood, MPE of [1-2H]- glucose in blood, M6(pGlcUA)urine, MPE of [U-13C]-UDPglucose 
measured in urinary Par-GlcUA; f(glc), fractional contribution of newly synthesized glucose to blood 
glucose; M2(glc)blood, MPE of [13C2]-glucose in blood; M2(FBP:MIDA)glc, theoretical MPE of [13C2]-
Fructose 1,6 biphosphate, calculated by MIDA using 13C-enrichment data of glucose; f(UDPglc), fractional 
contribution of newly synthesized glucose to UDPglc pool; M2(pGlcUA)urine, MPE of [13C2]-UDPglc, 
sampled as urinary Par-GlcUA; M2(FBP:MIDA)pGlcUA, theoretical MPE of [13C2]-Fructose 1,6 
biphosphate, calculated by MIDA using 13C enrichment data of urinary Par-GlcUA; Ra(glc;whole body), 
whole body rate of appearance of glucose into the blood glucose pool; Inf(glc), rate of infusion of [U-
13C]glucose in μmol.kg-1.min-1; Ra(UDPglc;whole body), whole body rate of appearance of UDPglc; 
Inf(gal), rate of infusion of [1-2H]galactose in μmol.kg-1.min-1; MCR(glc), metabolic clearance rate of 
blood glucose; glc conc, blood glucose concentration in mmol.L-1; Ra(glc;endo), rate of endogenous blood 
glucose appearance, not corrected for recycling of tracer; Ra(UDPglc;endo), rate of endogenous UDP 
glucose appearance, not corrected for recycling of tracer; Rr(glc), rate of recycling of glucose tracer; 
Rr(UDPglc), rate of recycling of UDPglc tracer; totalRa(glc;endo), total endogenous glucose production, 
including recycling of tracer; totalRa(UDPglc), total endogenous UDPglucose production, including 
recycling of tracer; UDPglc(glc), rate of UDPglucose conversion into blood glucose; glc(UDPglc), rate of 
blood glucose conversion into UDPglucose; GNG(glc), rate of gluconeogenesis into blood glucose; 
GNG(UDPglc), rate of gluconeogenesis into UDPglucose; GNG(glc;indirect), rate of gluconeogenesis into 
blood glucose indirectly via glycogen; GNG(UDPglc;indirect), rate of gluconeogenesis into UDPglucose 
indirectly via blood glucose; GNG(glc;direct), rate of gluconeogenesis directly into blood glucose; 
GNG(UDPglc;direct), rate of gluconeogenesis directly into UDPglucose; GLY(glc), rate of glycogenolysis 
contributing to blood glucose formation; GLY (UDPglc), rate of glycogenolysis contributing to 
UDPglucose formation; GNG(G6P), total flux of G6P de novo synthesis, corrected for the exchange 
between blood glucose and UDPglucose pools; GK, glucokinase flux; G6Pase, glucose-6-phosphatase flux; 
GS, glycogen synthase flux; GP, glycogen phosphorylase flux.
Legend Supplementary Table 1
S1
Supplementary Table 1 Parameters and equations used to calculate hepatic glucose metabolism
[f(glc) x glc(UDPglc)] + [f(UDPglc) x Rr(UDPglc)]21. GNG(UDPglc;indirect)
[f(UDPglc) x UDPglc(glc)] + [f(glc] x Rr(glc)]20. GNG(glc;indirect)
GNG(UDPglc) - GNG(UDPglc;indirect) 23. GNG(UDPglc;direct)
GNG(glc) - GNG(glc;indirect)22. GNG(glc;direct)
c(UDPglc) x [Ra(glc;endo) + Inf(glc;total)]16. UDPglc(glc) 
Ra(UDPglc;endo) + Rr(UDPglc)15. Total Ra(UDPglc;endo)
c(glc) x [Ra(UDPglc;endo) + Inf(gal;total)]17. glc(UDPglc) 
GNG(UDPglc) + GLY(UDPglc)29. GS
GNG(glc) + GLY(glc)28. G6Pase
glc(UDPglc) + Rr(glc)27. GK
GNG(glc;direct) + GNG(UDPglc;direct)26. GNG(G6P)
GLY(UDPglc) + GLY(glc) + {[ 1- c(glc)] x Rr(UDPglc)}30. GP
Individual fluxes comprising hepatic G6P metabolism
Ra(UDPglc;endo) - GNG(UDPglc;direct) - glc(UDPglc)25. GLY(UDPglc)
Ra(glc;endo) - GNG(glc;direct) - [f(UDPglc) x UDPglc(glc)]24. GLY(glc)
f(UDPglc) x [Ra(UDPglc;whole body) + Rr(UDPglc)]19. GNG(UDPglc)
f(glc) x [Ra(glc;whole body) + Rr(glc)]18. GNG(glc)
Ra(glc;endo) + Rr(glc)14. Total Ra(glc;endo)
{c(UDPglc)/[1-c(UDPglc)]}/Ra(UDPglc;endo)13. Rr(UDPglc)
{c(glc)/[1-c(glc)]}/Ra(glc;endo)12. Rr(glc)
Ra(UDPglc;whole body) - Inf(gal;total)11. Ra(UDPglc;endo)
Ra(glc;whole body) - Inf(gal;total)10. Ra(glc;endo)
Ra(glc;whole body)/glc conc9. MCR(glc)




















Schematic model of hepatic carbohydrate metabolism. Major metabolic pathways and enzymatic reactions 
are depicted, despite glycolysis, sharing glucose-6-phosphate (G6P) as a central metabolite. The pathways 
included are: (1) Gluconeogenic flux toward G6P, (2) Glycogen phosphorylase flux, (3) Glucose-6-
phosphatase flux, (4) Glucokinase flux and (5) Glycogen synthase flux. Mice received an infusion 
containing [U-13C]glucose, [2-13C]glycerol, [1-2H]galactose and paracetamol for six hours. Mass 
isotopomer distribution analysis (MIDA) was applied on blood glucose and urinary paracetamol 
glucuronide samples.
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